Cart
sales@molnova.com
Emricasan
CAS No. 254750-02-2
Emricasan( IDN-6556 | PF-03491390 )
Catalog No. M13761 CAS No. 254750-02-2
Emricasan (IDN-6556;PF-03491390) is a potent, irreversible pan-caspase inhibitor, shows neuroprotective activity for hNPCs, inhibits ZIKV-induced increased caspase-3 activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 98 | In Stock |
|
| 2MG | 48 | In Stock |
|
| 5MG | 79 | In Stock |
|
| 10MG | 133 | In Stock |
|
| 25MG | 240 | In Stock |
|
| 50MG | 390 | In Stock |
|
| 100MG | 574 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEmricasan
-
NoteResearch use only, not for human use.
-
Brief DescriptionEmricasan (IDN-6556;PF-03491390) is a potent, irreversible pan-caspase inhibitor, shows neuroprotective activity for hNPCs, inhibits ZIKV-induced increased caspase-3 activity.
-
DescriptionEmricasan (IDN-6556;PF-03491390) is a potent, irreversible pan-caspase inhibitor, shows neuroprotective activity for hNPCs, inhibits ZIKV-induced increased caspase-3 activity.Steatohepatitis Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsIDN-6556 | PF-03491390
-
PathwayApoptosis
-
TargetCaspase
-
RecptorCaspase
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number254750-02-2
-
Formula Weight569.51
-
Molecular FormulaC26H27F4N3O7
-
Purity>98% (HPLC)
-
SolubilityDMSO: 93 mg/mL (163.3 mM); Ethanol: 93 mg/mL (163.3 mM); Water: <1 mg/mL （ < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESO=C(O)C[C@H](NC([C@H](C)NC(C(NC1=CC=CC=C1C(C)(C)C)=O)=O)=O)C(COC2=C(F)C(F)=CC(F)=C2F)=O
-
Chemical Name(3S)-3-[[(2S)-2-[[2-(2-tert-butylanilino)-2-oxoacetyl]amino]propanoyl]amino]-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Xu M, et al. Nat Med. 2016 Oct;22(10):1101-1107.
2. Brumatti G, et al. Sci Transl Med. 2016 May 18;8(339):339ra69.
3. McCall MD, et al. Transplantation. 2012 Jul 15;94(1):30-5.
molnova catalog
related products
-
Abrine
Abrine exhibits inhibition of rabbit small intestine indoleamine 2, 3-dioxygenase, competitive inhibition of IDO.
-
Lucidenic acid B
Lucidenic acid B (Lucidenicacid B), a natural compound extracted from Ganoderma lucidum, induces activation of caspase-9 and caspase-3 and cleavage of PARP, which can induce apoptosis in human leukemia cells through mitochondrial mediation.
-
Gypenoside XVII
Gypenoside XVII confers protection against Aβ25-35-induced neurotoxicity through estrogen receptor-dependent activation of PI3K/Akt pathways, activation of Nrf2/ARE/HO-1 and inactivation of GSK-3β pathways.
